New Research findings were released earlier today from the Fragile X Conference including updated prevalence numbers as well as linking the Fragile X protein (FMRP1) to Autism. I don't even know what to say other than these numbers made my heart stop. On one hand, higher prevalence means higher exposure - which certainly leads to more funding for research. On the other hand, this isn't something I would ever want more people to have to live with. Here's the excerpts from the NFXF Twitter / FB feed.
From an unbiased based population study of 7,000 people to estimate the prevalence of Fragile X is now 1 in 151 females and 1 in 468 males. With this study there was signification elevation of symptoms of FXTAS and FXPOI in this study. That information was from Dr. Masha Mailick Seltzer, PhD, Director, University of Wisconsin Waisman Center
A second study showed prevalence results of 1 in 209 female and 1 in 401 males. This study was conducted by Flora Tassone, PhD, Research Biochemist, UC Davis MIND Institute, University of California
The previous numbers were 1 in 260 females and 1 in 800 males.
Anywhere from 2-6% of children with Autism will have FragileX Syndrome. There is a very close relationship between FragileX and Autism at the molecular level.
Read the full press release here: